Clinical Trials in New York

Showing 7541-7560 of 17,259 trials

Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma

NCT01129167

Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if the original cancer is surgically removed, microscopic areas of cancer often remain. Data on the patterns of local invasion by pancreatic cancer have not been published. In this study, The investigators hope to investigate the frequency of the various methods of local invasion of pancreatic adenocarcinoma. This would help the investigators better understand how pancreatic cancer spreads, and determine what cancers are not resectable.

Pancreatic Cancer

Columbia University1,052 participantsStarted Sep 2009

New York, New York, United States

COMPLETEDPhase 1< 1 mile

First in Human Study of M4344 in Participants With Advanced Solid Tumors

NCT02278250

The purpose of this study was to evaluate the safety and tolerability of multiple ascending doses of single-agent M4344 administered twice-weekly (BIW), twice daily (BID) or once daily dose schedule in participants with advanced solid tumors. This investigation is a three part study examining M4344 alone and in combination with carboplatin to determine the safety and maximum tolerated dose.

Solid TumorAdvanced Solid Tumor

EMD Serono Research & Development Institute, Inc.97 participantsStarted Jan 2015

Boston, Massachusetts, United States • Ann Arbor, Michigan, United States • St Louis, Missouri, United States +13 more locations

Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Find Trials by Condition in New York

Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

FREEDOM COVID-19 Anticoagulation Strategy

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis

A Prospective Clinical Study of Phenylketonuria (PKU)

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study